Tumor and Development (TED)

CompletedOBSERVATIONAL

Enrollment

998

Participants

Timeline

Start Date

June 1, 2013

Primary Completion Date

December 1, 2022

Study Completion Date

December 1, 2022

Conditions

Tumor and Abnormalities of the Development

Interventions

OTHER

blood and tumor samples

all tumor pathology associated with anomaly of development

Trial Locations (1)

Hôpital Necker Enfants Malades, Paris

All Listed Sponsors

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT01915797 - Tumor and Development (TED) | Biotech Hunter | Biotech Hunter